PB1046 Subcutaneous Injection

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
86	肺動脈性肺高血圧症	8

86. 肺動脈性肺高血圧症

臨床試験数 : 1,205 / 薬物数 : 684 - (DrugBank : 124) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 193

trials per page:

Showing 1 to 8 of 8 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2019-001598-10-AT (EUCTR)	29/04/2021	23/01/2020	Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly Subcutaneous Injections of ...	A Randomized, Double-Blind, Parallel Group, Phase 2 Study to Assess the Safety, Tolerability, and Ef ...	Symptomatic Pulmonary Arterial Hypertension MedDRA version: 21.1;Level: PT;Classification code 10064 ...	Product Name: Vasomera (PB1046) Injection Product Code: PB1046 INN or Proposed INN: not available Other ...	PhaseBio Pharmaceuticals, Inc.	NULL	Not Recruiting			Female: yes Male: yes	63	Phase 2	Serbia;United States;Greece;Spain;Austria;Italy;Czech Republic;Hungary;Belgium;Poland;Romania;Bulgar ...
2	EUCTR2019-001598-10-PL (EUCTR)	26/05/2020	13/02/2020	Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly Subcutaneous Injections of ...	A Randomized, Double-Blind, Parallel Group, Phase 2 Study to Assess the Safety, Tolerability, and Ef ...	Symptomatic Pulmonary Arterial Hypertension MedDRA version: 21.1;Level: PT;Classification code 10064 ...	Product Name: Vasomera (PB1046) Injection Product Code: PB1046 INN or Proposed INN: not available Other ...	PhaseBio Pharmaceuticals, Inc.	NULL	Not Recruiting			Female: yes Male: yes	63	Phase 2	Serbia;United States;Czechia;Greece;Spain;Austria;Italy;Hungary;Poland;Belgium;Romania;Bulgaria;Germ ...
3	EUCTR2019-001598-10-ES (EUCTR)	28/02/2020	20/12/2019	Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly Subcutaneous Injections of ...	A Randomized, Double-Blind, Parallel Group, Phase 2 Study to Assess the Safety, Tolerability, and Ef ...	Symptomatic Pulmonary Arterial Hypertension MedDRA version: 21.1;Level: PT;Classification code 10064 ...	Product Name: Vasomera (PB1046) Injection Product Code: PB1046 INN or Proposed INN: not available Other ...	PhaseBio Pharmaceuticals, Inc.	NULL	Not Recruiting			Female: yes Male: yes	63	Phase 2	Serbia;United States;Greece;Spain;Austria;Italy;Czech Republic;Hungary;Belgium;Poland;Romania;Bulgar ...
4	EUCTR2019-001598-10-GR (EUCTR)	28/02/2020	13/12/2019	Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly Subcutaneous Injections of ...	A Randomized, Double-Blind, Parallel Group, Phase 2 Study to Assess the Safety, Tolerability, and Ef ...	Symptomatic Pulmonary Arterial Hypertension MedDRA version: 21.1;Level: PT;Classification code 10064 ...	Product Name: Vasomera (PB1046) Injection Product Code: PB1046 INN or Proposed INN: not available Other ...	PhaseBio Pharmaceuticals, Inc.	NULL	Not Recruiting			Female: yes Male: yes	63	Phase 2	Serbia;United States;Greece;Spain;Austria;Italy;Czech Republic;Hungary;Belgium;Poland;Romania;Bulgar ...
5	EUCTR2019-001598-10-BG (EUCTR)	12/02/2020	09/01/2020	Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly Subcutaneous Injections of ...	A Randomized, Double-Blind, Parallel Group, Phase 2 Study to Assess the Safety, Tolerability, and Ef ...	Symptomatic Pulmonary Arterial Hypertension MedDRA version: 21.1;Level: PT;Classification code 10064 ...	Product Name: Vasomera (PB1046) Injection Product Code: PB1046 INN or Proposed INN: not available Other ...	PhaseBio Pharmaceuticals, Inc.	NULL	Not Recruiting			Female: yes Male: yes	63	Phase 2	Serbia;United States;Greece;Spain;Austria;Italy;Czech Republic;Hungary;Belgium;Poland;Romania;Bulgar ...
6	EUCTR2019-001598-10-HU (EUCTR)	24/01/2020	10/12/2019	Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly Subcutaneous Injections of ...	A Randomized, Double-Blind, Parallel Group, Phase 2 Study to Assess the Safety, Tolerability, and Ef ...	Symptomatic Pulmonary Arterial Hypertension MedDRA version: 21.1;Level: PT;Classification code 10064 ...	Product Name: Vasomera (PB1046) Injection Product Code: PB1046 INN or Proposed INN: not available Other ...	PhaseBio Pharmaceuticals, Inc.	NULL	Not Recruiting			Female: yes Male: yes	63	Phase 2	Serbia;United States;Greece;Spain;Austria;Italy;Hungary;Czech Republic;Belgium;Poland;Romania;Bulgar ...
7	NCT03795428 (ClinicalTrials.gov)	April 10, 2019	18/12/2018	Long-Term, Open Label Extension Study of Pemziviptadil (PB1046) in PAH Subjects Following Completion ...	A Long-Term, Open Label Extension Study of Pemziviptadil (PB1046) Subcutaneous Injections in Pulmona ...	Pulmonary Arterial Hypertension	Drug: Pemziviptadil (PB1046) Injection	PhaseBio Pharmaceuticals Inc.	NULL	Recruiting	18 Years	79 Years	All	63	Phase 2	United States
8	NCT03315507 (ClinicalTrials.gov)	October 20, 2017	2/10/2017	A Study to Assess the Safety, Tolerability, and Hemodynamic Response of PB1046 in Subjects With PAH	An Open-Label, Dose Titration Study to Assess the Safety, Tolerability, and Hemodynamic Response of ...	Pulmonary Arterial Hypertension	Drug: PB1046 Subcutaneous Injection	PhaseBio Pharmaceuticals Inc.	NULL	Completed	18 Years	N/A	All	3	Phase 1	United States

First Previous1Next Last